Long‐term safety of a weekly and monthly subcutaneous buprenorphine depot (CAM2038) in the treatment of adult out‐patients with opioid use disorder-Reference-Cited by-同舟云学术

Long‐term safety of a weekly and monthly subcutaneous buprenorphine depot (CAM2038) in the treatment of adult out‐patients with opioid use disorder

Published:2019-06-03 Issue:8 Volume:114 Page:1416-1426
ISSN:0965-2140
Container-title:Addiction
language:en
Short-container-title:Addiction

Author:

Frost Michael¹,Bailey Genie L.²³,Lintzeris Nicholas⁴⁵,Strang John⁶^ORCID,Dunlop Adrian⁷⁸,Nunes Edward V.⁹^ORCID,Jansen Jakob Billeskov¹⁰,Frey Lars Chemnitz¹¹,Weber Bernd¹²,Haber Paul¹³¹⁴,Oosman Sonia¹⁵,Kim Sonnie¹⁵^ORCID,Tiberg Fredrik¹⁶

Affiliation:

1. The Frost Medical Group, LLC Conshohocken PA USA

2. Warren Alpert Medical School of Brown University Providence RI USA

3. Stanley Street Treatment and Resources, Inc. Fall River MA USA

4. Discipline of Addiction MedicineUniversity of Sydney Surry Hills NSW Australia

5. South East Sydney Local Health District Surry Hills NSW Australia

6. King'’s College London, National Addiction CentreInstitute of Psychiatry, Psychology and Neuroscience London UK

7. Hunter Medical Research InstituteUniversity of Newcastle Newcastle NSW Australia

8. Hunter New England Local Health District Newcastle NSW Australia

9. Columbia University Medical Center New York NY USA

10. Højbjerg Denmark

11. Behandlingscenter Odense Odense C Denmark

12. Praxiszentrum Friedrichsplatz, Competence Center for Addiction Medicine Kassel Germany

13. Discipline of Addiction MedicineUniversity of Sydney Camperdown NSW Australia

14. Royal Prince Alfred Hospital Camperdown NSW Australia

15. Braeburn Inc. Plymouth Meeting PA USA

16. Camurus AB Lund Sweden

Publisher

Wiley

Subject

Psychiatry and Mental health,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/add.14636

Reference24 articles.

1. NCHS data brief, no. 273;Hedegaard H.,2017

2. Trends in heroin and pharmaceutical opioid overdose deaths in Australia

3. Increases in Drug and Opioid Overdose Deaths — United States, 2000–2014

4. United Nations Office on Drugs and Crime.World Drug Report 2017 (ISBN: 978–92–1‐148291‐1 eISBN: 978–92–1‐060623‐3 United Nations publication Sales no. E.17.XI.6). Available at:https://www.unodc.org/wdr2017/field/Booklet_1_EXSUM.pdf(Accessed 3 October 2017) (Archived athttp://www.webcitation.org/78LWGMXZM).

5. Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating preferences for medication formulation and treatment model among people who use opioids non-medically: A web-based cross-sectional study;Journal of Substance Use and Addiction Treatment;2024-08

2. An Australian retrospective observational cohort comparison of the use of long-acting injectable buprenorphine products;Journal of Substance Use and Addiction Treatment;2024-07

3. Provider Perceptions toward Extended-Release Buprenorphine for Treatment of Opioid Use Disorder;Journal of Addiction Medicine;2024-06-03

4. 96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial;International Journal of Drug Policy;2024-05

5. Patients' perspectives on buprenorphine subcutaneous implant: a case series;Journal of Medical Case Reports;2024-04-06